Analysts/Institutional Investor Meet/Con. Call Updates

Date: 05th November, 2026 The Manager, The Manager, Corporate Filings Department, Listing Compliance Department, BSE Limited, National Stock Exchange of India Ltd. Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot no. C/1, G Block, Dalal Street, Bandra-Kurla Complex, Bandra (E), Mumbai- 400 001 Mumbai - 400 051. Security Code: 532815 Symbol: SMSPHARMA Dear Sir/Madam, Sub: Audio recording of Analysts/Investors Conference Call pertaining to the Financial Results for the second quarter and half year ended 30th September, 2026. Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, and further to our letter dated 2nd November, 2026 regarding intimation of Investors/ Analyst conference call, held on today i.e., 5th November, 2026, on the un audited Financial Results of the Company for the second quarter and half year ended 30th September, 2026, we would like to inform you that the audio recording of the said call made available on the Company’s website. This can be accessed via the following link. https://smspharma.com/financials/audio-or-video-recording-of-investors-meet/ You are requested to take the same on record. Thanking you Yours Faithfully For SMS Pharmaceuticals Limited Ramesh Babu Potluri Chairman & Managing Director DIN: 00166381